InvestorsHub Logo
Followers 2
Posts 189
Boards Moderated 0
Alias Born 05/25/2010

Re: None

Tuesday, 10/14/2014 5:04:14 AM

Tuesday, October 14, 2014 5:04:14 AM

Post# of 3999
Source: www.breitbart.com/Breitbart-California/2014/10/11/Ebola-Drug-ZMapp-Production-Accelerated

“ZMapp is now made in genetically modified tobacco plants by Kentucky BioProcessing. Whaley said the Owensboro, KY company will continue production as fast as possible. At the same time, the new partner, whom Whaley declined to name, will scale up a more traditional biotech process using genetically modified mammalian cells. That process uses "CHO" cells, derived from Chinese hamster ovaries, grown in sterile tanks,” the San Diego Union Tribune reports."



I was doing some DD came up on this, but do you believe the Declined to name might be Protalix? Because Protalax uses advance genetically engineered plants (Tabacco)

Source: www.smallcapnetwork.com/PLX-Could-Win-Big-On-ZMapp-Production-Ramp/s/via/24698/article/view/p/mid/1/id/4/

Protalix's product, ProCellEx®is a next-generation recombinant protein expression system that uses advanced genetic engineering and plant (carrot and tobacco) cell culture technology instead of yeast-based systems, enabling the production of a wide range of complex, proprietary and biologically equivalent human proteins to address a variety of diseases. PLX drug ELELYSO is the first FDA-approved plant cell-based recombinant therapeutic protein.It is marketed under a partnership with Pfizer Inc, (NYSEMKT:PFE)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News